Empire Financial Management Company’s Gilead Sciences GILD Stock Holding History

Empire Financial Management Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$418K	Hold	3,000	–	–	0.09%	165
2025 Q4	$368K	Buy	3,000 +400	+15%	+$48.6K	0.08%	170
2025 Q3	$289K	Hold	2,600	–	–	0.07%	179
2025 Q2	$288K	Hold	2,600	–	–	0.08%	170
2025 Q1	$291K	Hold	2,600	–	–	0.09%	172
2024 Q4	$240K	Hold	2,600	–	–	0.07%	182
2024 Q3	$218K	Sell	2,600 -600	-19%	-$45.8K	0.07%	198
2024 Q2	$220K	Hold	3,200	–	–	0.07%	191
2024 Q1	$234K	Hold	3,200	–	–	0.08%	190
2023 Q4	$259K	Sell	3,200 -200	-6%	-$15.6K	0.1%	175
2023 Q3	$255K	Hold	3,400	–	–	0.11%	169
2023 Q2	$262K	Sell	3,400 -1,200	-26%	-$95.7K	0.1%	175
2023 Q1	$382K	Buy	+4,600	New	+$381K	0.16%	142

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Empire Financial Management Company's GILD Position: Q1 2026 in Review

Empire Financial Management Company held its Gilead Sciences (GILD) position steady in Q1 2026 at 3,000 shares worth $418K. The position accounts for 0.09% of the portfolio, ranked #165.

Empire Financial Management Company first reported a position in GILD in Q1 2023 and has held it in 13 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Empire Financial Management Company held 3,000 shares of Gilead Sciences worth $418K as of Q1 2026.
Empire Financial Management Company left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.09% of Empire Financial Management Company's portfolio in Q1 2026, its #165 holding.
Empire Financial Management Company first reported a position in Gilead Sciences in Q1 2023 and has held it in 13 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Empire Financial Management Company's 13F filing for Q1 2026, filed 18 May 2026.